“…C. elegans shows avoidance of the urine of healthy individuals while displaying a chemotactic attraction toward the urine of patients with 15 types of cancer (stomach, colon-rectum, lung, breast, pancreas, liver, prostate, uterus, esophagus, gallbladder, bile duct, kidney, urinary bladder, ovary, oropharynx) rendering N-NOSE a primary multi-cancer screening test [ 20 , 24 , 25 , 30 , 31 ]. N-NOSE clinical studies with human patients from cancer stages 0 to Ⅳ have highlighted the good performance at early detection (stages 0-Ⅰ) without lymphatic metastasis, in addition to detecting advanced stages [ 20 , 24 , 25 , 30 , 31 ]. This test only requires ≥1 mL of urine, which is non-invasive, painless, and stress-free for the subject [ 20 , 28 ].…”